Table 2
Distribution of HIV prevalence within exposure categories by source and region
| London | Outside London | Total | |||||
|---|---|---|---|---|---|---|---|
| GP | GUM | OR* (95% CI) | GP | GUM | OR* (95% CI) | ||
| *Odds ratios compare HIV prevalence of GP to GUM (GP = general practice; GUM = genitourinary medicine). | |||||||
| Homosexual and bisexual men | |||||||
| Total number tested | 141 | 13734 | 520 | 8290 | 22685 | ||
| HIV prevalence | 15.6% | 8.5% | 1.98 (1.20–3.16) | 3.7% | 4.1% | 0.89 (0.53 to 1.44) | 6.8% |
| Modal age group | 25–29 | 25–29 | 20–24 | 20–24 | 25–29 | ||
| Injecting drug users | |||||||
| Total number tested | 981 | 2273 | 1556 | 2408 | 7175 | ||
| HIV prevalence | 1.3% | 4.4% | 0.29 (0.15 to 0.52) | 0.5% | 1.3% | 0.38 (0.15 to 0.85) | 2.1% |
| Modal age group | 30–34 | 25–29 | 20–24 | 20–24 | 25–29 | ||
| Female heterosexuals: | |||||||
| Total number tested (%) | 472 (100) | 26289 (100) | 1654 (100) | 26670 (100) | 55085 (100) | ||
| HIV prevalence | 2.5% | 1.6% | 1.64 (0.83 to 2.92) | 0.4% | 0.3% | 1.45 (0.56 to 3.14) | 0.9% |
| Modal age group | 20–24 | 20–24 | 20–24 | 20–24 | 20–24 | ||
| High risk partner | |||||||
| Total number tested (%) | 74 (16) | 1740 (7) | 311 (19) | 1957 (7) | 4082 (7) | ||
| HIV prevalence | 0.0% | 0.6% | n/a | 0.0% | 0.2% | n/a | 0.3% |
| Modal age group | 20–24 | 25–29 | 25–29 | 20–24 | 20–24 | ||
| Lived in Africa | |||||||
| Total number tested (%) | 65 (14) | 1754 (7) | 78 (5) | 394 (1) | 2291 (4) | ||
| HIV prevalence | 16.9% | 16.1% | 1.06 (0.50–2.09) | 7.7% | 9.1% | 0.83 (0.28 to 2.09) | 14.6% |
| Modal age group | 25–29 | 25–29 | 25–29 | 25–29 | 25–29 | ||
| Other | |||||||
| Total number tested (%) | 333 (71) | 22795 (87) | 1265 (76) | 24319 (91) | 48712 (88) | ||
| HIV prevalence | 0.3% | 0.5% | 0.57 (0.01 to 3.25) | 0.1% | 0.2% | 0.49 (0.01 to 2.92) | 0.3% |
| Modal age group | 25–29 | 25–29 | 25–29 | 25–29 | 25–29 | ||
| Male heterosexuals: | |||||||
| Total number tested (%) | 399 (100) | 21129 (100) | 1854 (100) | 26340 (100) | 49722 (100) | ||
| HIV prevalence | 3.8% | 1.4% | 2.71 (1.48 to 4.60) | 0.2% | 0.3% | 0.68 (0.18 to 1.80) | 0.8% |
| Modal age group | 25–29 | 25–29 | 20–24 | 20–24 | 25–29 | ||
| High risk partner | |||||||
| Total number tested (%) | 13 (3) | 446 (2) | 118 (6) | 505 (2) | 1082 (2) | ||
| HIV prevalence | 0.0% | 1.6% | n/a | 0.0% | 0.6% | n/a | 0.9% |
| Modal age group | 25–29 | 25–29 | 25–29 | 20–24 | 25–29 | ||
| Lived in Africa | |||||||
| Total number tested (%) | 76 (19) | 1869 (9) | 176 (9) | 609 (2) | 2730 (5) | ||
| HIV prevalence | 13.2% | 10.0% | 1.37 (0.62 to 2.74) | 1.7% | 6.2% | 0.26 (0.05 to 0.84) | 8.7% |
| Modal age group | 25–29 | 25–29 | 35–39 | 25–29 | 25–29 | ||
| Other | |||||||
| Total number tested (%) | 310 (78) | 18814 (89) | 1560 (84) | 25226 (96) | 45910 (92) | ||
| HIV prevalence | 1.6% | 0.6% | 2.87 (0.91 to 6.97) | 0.1% | 0.2% | 0.38 (0.01 to 2.21) | 0.3% |
| Modal age group | 20–24 | 25–29 | 20–24 | 20–24 | 25–29 | ||
